ACST,Acasti Pharma Inc. | Healthcare

Healthcare

ACST

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Acasti Pharma Inc.ACST

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage.

It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia.

The company was incorporated in 2002 and is headquartered in Laval, Canada.

Latest News >

Axis Capital Says Matthew Kirk Assuming CFO Role

Mar 26, 2026

09:37 AM EDT, 03/26/2026 (MT Newswires) -- Axis Capital ( AXS/PE ) said Thursday that Matthew Kirk is assuming the role of chief financial officer, effective March 31. Kirk was previously the CFO of Enstar Group, Axis Capital ( AXS/PE ) said. Price: 101.04, Change: -0.42, Percent Change: -0.41 ...

BMO hires CIBC's Kostandoff to co-lead equity capital markets team

Mar 26, 2026

TORONTO, March 26 (Reuters) - Bank of Montreal ( NRGD ) has hired Joe Kostandoff from CIBC to co-head its global equity capital markets team as veteran Peter Miller will move to a vice chair role, according to a memo seen by Reuters. Here are some details: * Kostandoff will partner with Eric Benedict to lead the bank's global ECM...

Gold Falls as Investors Turn to the Dollar With the War on Iran Threatening Higher Inflation

Mar 26, 2026

09:20 AM EDT, 03/26/2026 (MT Newswires) -- Gold futures fell early Thursday, retreating as oil prices rise along with the dollar and bond yields. Gold for April delivery was last seen down $113.90 to US$4,471.60 per ounce. The price of the precious metal is down 13% since the Feb. 28 start to the war on Iran. While normally seen as...

Firefly Stock Jumps On Department Of Defense Partnership

Mar 26, 2026

Firefly Neuroscience, Inc. ( AIFF ) shares are trading higher Thursday after the company announced a public-private partnership with the Department of Defense. Firefly shares are climbing with conviction. What’s behind AIFF gains? Department Of Defense Partnership Expands Commercial Footprint Firefly said the partnership will support the assessment and treatment of active-duty U.S. service members and veterans suffering from post-traumatic stress...